Jorden David Emerson

CEO/CFO, DirectorNuo Therapeutics, Inc. (AURX) · full profile →Form 4 · filed Nov 14, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$244K
Net Open-Market Flow
-$244K
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 9, 2022Sell(S)20K$1.50$30K2.0M
Nov 9, 2022Sell(S)10K$1.50$15K2.0M
Nov 9, 2022Sell(S)5K$1.50$8K2.0M
Nov 9, 2022Sell(S)7K$1.50$11K2.0M
Nov 9, 2022Sell(S)30K$1.50$45K2.1M
Nov 9, 2022Sell(S)14K$1.50$20K2.0M
Nov 9, 2022Sell(S)27K$1.50$41K2.1M
Nov 9, 2022Sell(S)30K$1.50$45K2.1M
Nov 9, 2022Sell(S)20K$1.50$30K2.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-027386) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about AURX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-22-027386"
Ask your agent
Use Arkolith to summarize insider buying and selling at Nuo Therapeutics, Inc.
over the last 90 days and cite the filings.